人类白细胞抗原HLA氨基酸残基配型在角膜移植供受体选择中的应用  被引量:1

Clinical application of HLA amino acid residue matching in choice of donor and recipient before keratoplasty

在线阅读下载全文

作  者:陈梅珠[1] 惠延年[1] 

机构地区:[1]第四军医大学西京医院眼科,中国陕西省西安市710032

出  处:《国际眼科杂志》2007年第3期727-729,共3页International Eye Science

摘  要:目的:探讨人类白细胞抗原(human leucocyte antigen,HLA)氨基酸残基配型在角膜移植排斥反应中的作用程度,以及术前进行HLA配型的临床意义。方法:角膜移植患者91例92眼,其中高危角膜50例50眼,非高危角膜41例42眼。HLA-Ⅰ,Ⅱ类抗原分别由一步单抗法和DNA法检测。根据HLA氨基酸残基的相配数分为HLA的低错配组(2错配、3错配)和高错配组(4错配、5错配)。结果:高危组的排斥反应率74.0%明显高于非高危组31.0%(P=0.001)。在高危组中,HLA高错配的排斥反应率高达84.8%,明显高于低错配的52.9%(P=0.021),而且高错配组发生排斥反应的危险性是低错配组的1.6倍(RR=1.6)。在非高危组中:HLA高错配的排斥反应率30.4%与低错配的31.6%比较无统计学意义(P=0.936)。结论:高危角膜患者HLA高错配组的排斥反应率高于低错配组,术前进行HLA配型有临床指导意义,而对非高危角膜配型无意义。AIM: To evaluate the importance of human leucocyte antigen (HLA) amino add residue matching in keratoplasty before corneal transplantation. METHODS: There were 92 recipient eyes in 92 cases divided into high-risk (50 eyes) and low-risk (42 eyes) groups according to the degree of neovascularization or corneal ulcer with no response to treatment. The cases were subdivided into two groups: high-mismatching (MM) group composed of 4 MM and 5 MM and Iow-MM group composed of 2 MM and 3MM. HLA-Ⅰ, HLA-Ⅱ were typed by monoclonial antibody and DNA-based method before surgery, respectively. RESULTS: The rejection rate in high-risk (74.0%) was significantly higher than that in low-risk (31.0%), (P=-0.001〈0.05). In high-risk group, the rejection rate in high-MM group (84.8%) was much higher by 1.6 times than that in low-MM (52.9%) (P=-0.021〈0.05, RR=1.6). However, in low-risk group there was no significant difference of rejection rate between high-MM (30.40/0) and Iow-MM (31.6%) (P=-0.936〉0.05). CONCLUSION: The results showed that HLA amino acid residue matching play an important role in reducing rejection rate, indicating that accurate HLA typing is necessary before keratoplasty. If possible, the better matched donor-recipient should be chosen according to the HLA amino acid residue matching especially in high-risk group with severe neovascularization.

关 键 词:人类白细胞抗原HLA 氨基酸残基配型 角膜移植 

分 类 号:R779.65[医药卫生—眼科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象